StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

Rallybio profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Rallybio's profit margin for the twelve months ending Sep 30, 2026 was 6177.4%. For fiscal 2025 it was -1046.4%, against -9084.1% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1046.4%+8037.7
FY2024Dec 31, 2024-9084.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-3904.7%+547.6
Q4 FY2025Dec 31, 2025-2636.0%+26427.1
Q3 FY2025Sep 30, 20257554.7%+11389.5
Q2 FY2025Jun 30, 2025-4576.9%+853.2
Q1 FY2025Mar 31, 2025-4452.4%–
Q4 FY2024Dec 31, 2024-29063.2%–
Q3 FY2024Sep 30, 2024-3834.8%–
Q2 FY2024Jun 30, 2024-5430.1%–

More Rallybio figures

See a number that looks wrong?